The U.S. FDA has granted Emergency Use Authorization for CTK Biotech’s ImmuView® COVID-19 Antigen Home Test On December 20th, CTK Biotech obtained the FDA’s Emergency Use Authorization for their ImmuView® COVID-19 Antigen Home Test, a few months after being the first to receive the WHO Emergency Use Listing for their international brand, OnSite® COVID-19 Ag Self Test. The FDA EUA.... Read Full Article >
World Malaria Day On April 25, 2016 people around the world will participate in World Malaria Day, taking part in events to fight against and raise awareness about malaria. Facts about Malaria1 : 3.2 billion people in 97 countries – nearly half of the world’s population – are currently at risk for malaria disease transmission Roughly 15 countries – mainly.... Read Full Article >
CTK Biotech, Inc. and the United States Centers for Disease Control and Prevention (CDC) have reached a license agreement that grants CTK the worldwide-exclusive, diagnostic commercial rights to a patented dengue virus developed by a CDC laboratory. Utilizing this advanced technology, CTK has recently launched an improved line of its OnSite Rapid Tests for the detection of anti-dengue IgG and.... Read Full Article >